A retrospective study published in Asian Pacific Journal of Cancer Prevention found that season of recurrence, but not season of diagnosis, is significantly associated with survival outcomes in epithelial ovarian cancer patients. Epithelial ovarian cancer (EOC) is cancer that begins in the ovaries and is the eighth most common cause of death from cancer in women. Recurrent EOC refers to individuals who reach complete remission following initial treatment and are therefore free of the cancer, but then experience a return of cancer cells. The five year survival rate for EOC patients in the United States is 45%, mainly due to the cancer’s high rate of recurrence. The growth-inhibiting mechanisms by which vitamin D helps stop tumor progression, as well as the other anti-cancer effects of vitamin D, are continuously being researched. Experimental studies have shown that activated vitamin D promotes cell differentiation and reduces the invasive potential of cancer cells in patients with metastasis.
Posted on: Fri, 28 Nov 2014 13:28:43 +0000
Trending Topics
Recently Viewed Topics
© 2015